| Identification | |
| Name: | Yohimban-16-carboxylicacid,11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]oxy]-,methyl ester, (3b,16b,17a,18b,20a)- |
| Synonyms: | 3b,20a-Yohimban-16b-carboxylic acid, 18b-hydroxy-11,17a-dimethoxy-, methyl ester, 3,4,5-trimethoxycinnamate(ester) (8CI); Rescinnamine (6CI); Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]oxy]-,methyl ester, (3b,16b,17a,18b,20a)- (9CI);Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.;3,4,5-Trimethoxycinnamoyl methyl reserpate; Anaprel; Apoterin; Apoterin S;Cartric; Cinnaloid; Methyl trimethoxycinnamoylreserpate; Moderil; NSC 15628;O-(3,4,5-Trimethoxy-trans-cinnamoyl) methyl reserpate; Rescinnamin; Rescisan;Resealoid; Reserpic acid methyl ester 3,4,5-trimethoxycinnamate; Reserpinine;Reserpinine (C35 alkaloid); Scinnamina |
| CAS: | 24815-24-5 |
| EINECS: | 246-471-8 |
| Molecular Formula: | C35H42 N2 O9 |
| Molecular Weight: | 634.79 |
| InChI: | InChI=1/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | 1544 |
| Melting Point: | 238 C |
| Flash Point: | 411.5°C |
| Boiling Point: | 756.8°C at 760 mmHg |
| Density: | 1.31g/cm3 |
| Stability: | Stable, but darkens slowly in light. Incompatible with strong oxidizing agents. |
| Refractive index: | 1.621 |
| Water Solubility: | negligible Stability Stable, but darkens slowly in light. Incompatible withstrong oxidizing agents. Toxicology Harmful if swallowed. May be harmful if inhaled. Toxicity data |
| Solubility: | negligible
|
| Appearance: | white to cream powder |
| Packinggroup: | III |
| Flash Point: | 411.5°C |
| Color: | Fine needles from benzene WHITE, OR PALE BUFF TO CREAM-COLORED CRYSTALLINE POWDER |
| Safety Data | |
 |
|
